Sexual and Reproductive Health Integration Advocacy Roadmap

This roadmap addresses the critical need for integrated sexual and reproductive health (SRH) and HIV services. This integration is essential for enhancing public health outcomes, socio-economic benefits, and individual health and rights. The Roadmap aims to revitalize and sustain advocacy efforts for SRH and HIV integration, empower communities to hold stakeholders accountable for implementation, increase political and program support to enable the shift from policy to practice, and foster dynamic partnerships across research, advocacy, implementation, and policy sectors.

It was developed by Copper Rose Zambia (CRZ) as part of the Coalition to Accelerate and Support Prevention Research (CASPR). It draws on extensive input, including desk reviews, interviews, focus group discussions, and a specialized workshop held at the 2023 International Conference on AIDS and STIs in Africa (ICASA).

Global Investment in HIV Cure Research & Development in 2021

A decade of progress

MTN 043/ B-PROTECTED

HVTN 135

HVTN 805/ HPTN 093

Voluntary Medical Male Circumcision for HIV Prevention (VMMC): An introductory factsheet

This introductory 2-page document explains how VMMC works, reviews the scientific evidence behind it, and outlines key advocacy issues for implementing it.

Trial Trial Again: Getting research right for adolescents

Both research and advocacy for HIV prevention are intensifying their focus on young people. Bringing interventions that work for this population holds unique challenges.

In this episode of AVAC’s Px Pulse podcast series, AVAC’s Manju Chatani-Gada explores how and why prevention research must reach the next generation.

Treatment as Prevention: An introductory factsheet

This introductory 2-page document defines treatment as prevention, reviews the scientific evidence behind it, and outlines implementation advocacy priorities. The factsheet is part of a series on emerging HIV prevention strategies.

Community Involvement in HIV Prevention Research: Experiences and perceptions of communities participating in the MDP 301 microbicide trial in Masaka, Uganda

This case study by 2010 AVAC Advocacy Fellow Richard Hasunira assesses the community engagement efforts of the Masaka trial site through interviews with participants, trial staff, and other stakeholders. It highlights success that other trials should replicate and lessons learned from shortcomings.

Ugandan Service Provider Perspectives on the WHO Recommendation on Hormonal Contraceptives and HIV Risk

This abstract poster, developed by 2012 AVAC Advocacy Fellow Lydia Mulwanyi-Mukombe and her Host, Lillian Mworeko, describes key findings from consultations with Uganda service providers. It reports how providers were planning to use the new WHO guidance and makes recommendations for how to protect and inform women in light of the potential HIV risk associated with hormonal contraceptive use.